Tazemetostat Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 12, 2020.
For the Consumer
Applies to tazemetostat: oral tablets
Side effects include:
For Healthcare Professionals
Applies to tazemetostat: oral tablet
Very common (10% or more): Hemoglobin decreased (49%), decreased lymphocytes (36%), white blood cell count decreased (19%), hemorrhage (e.g., wound hemorrhage, rectal hemorrhage, pulmonary hemorrhage, hemorrhage intracranial, cerebral hemorrhage, hemoptysis) (18%), anemia (16%), partial thromboplastin time increased (15%)[Ref]
Very common (10% or more): Triglycerides increased (36%), glucose increased (33%), sodium decreased (30%), phosphate decreased (28%), anorexia (26%), albumin decreased (23%), alkaline phosphatase increased (23%), potassium decreased (20%), weight loss (16%), calcium decreased (16%), glucose decreased (16%), potassium increased (12%)[Ref]
Very common (10% or more): Aspartate aminotransferase increased (18%), alanine aminotransferase increased (14%)[Ref]
Very common (10% or more): Pain (e.g., tumor pain, pain in extremity, non-cardiac chest pain, flank pain, back pain, arthralgia, bone pain, cancer pain, musculoskeletal pain, myalgia, neck pain) (52%), fatigue/asthenia (47%)[Ref]
The most common adverse reactions (20% or greater) were pain, fatigue, nausea, decreased appetite, vomiting, and constipation.[Ref]
Very common (10% or more): Creatinine increased (14%)[Ref]
1. "Product Information. Tazverik (tazemetostat)." Epizyme, Inc, Cambridge, MA.
More about tazemetostat
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: miscellaneous antineoplastics
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.